BioAffinity Technologies appoints Dr. Gordon Downie as Chief Medical Officer

BioAffinity Technologies (BIAF) announced the appointment of Gordon Downie, MD, PhD, as its new Chief Medical Officer. Dr. Downie brings over three decades of experience in pulmonary medicine, clinical research, medical innovation, and interventional pulmonology. He has previously worked in academic medicine and private practice, led FDA-approved research, and held national leadership roles with the American College of Chest Physicians. Most recently, he was Director of the Lung Nodule Clinic and Interventional Pulmonology at Titus Regional Medical Center.